Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Ann Thor

Concepts (434)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
64
2022
1846
4.010
Why?
Receptor, ErbB-2
24
2018
300
2.760
Why?
Metformin
10
2018
274
2.250
Why?
Tamoxifen
10
2020
190
1.550
Why?
Receptors, Estrogen
15
2020
371
1.470
Why?
Receptor, ErbB-3
8
2016
41
1.340
Why?
Cell Proliferation
15
2018
2173
1.210
Why?
Genes, erbB-2
8
2013
26
1.130
Why?
Mammary Neoplasms, Experimental
6
2017
64
1.090
Why?
Apoptosis
20
2018
2349
0.830
Why?
Cell Line, Tumor
22
2020
2700
0.770
Why?
Thyroid Hormones
1
2020
53
0.700
Why?
Up-Regulation
3
2020
802
0.690
Why?
Hormone Replacement Therapy
1
2020
76
0.680
Why?
Triple Negative Breast Neoplasms
3
2016
157
0.640
Why?
Mammary Neoplasms, Animal
3
2018
28
0.630
Why?
Disease-Free Survival
11
2020
618
0.610
Why?
Immunohistochemistry
24
2017
1624
0.580
Why?
Tumor Suppressor Protein p53
13
2011
445
0.570
Why?
Gene Expression Regulation, Neoplastic
18
2021
1145
0.560
Why?
Biomarkers, Tumor
10
2021
1032
0.550
Why?
ErbB Receptors
4
2010
554
0.550
Why?
Neoplasms, Germ Cell and Embryonal
3
2023
62
0.540
Why?
Testicular Neoplasms
3
2023
96
0.530
Why?
Antineoplastic Agents
9
2018
1875
0.520
Why?
Antineoplastic Combined Chemotherapy Protocols
9
2015
1356
0.520
Why?
Claudins
1
2016
24
0.510
Why?
Receptor, IGF Type 1
3
2016
58
0.490
Why?
Transcriptome
1
2020
723
0.490
Why?
Hypoglycemic Agents
3
2017
1011
0.470
Why?
Prognosis
17
2016
3315
0.460
Why?
Carcinogenesis
1
2016
175
0.460
Why?
Carcinoma, Ductal, Breast
5
2002
76
0.450
Why?
Estradiol
2
2009
450
0.440
Why?
Cell Cycle
4
2013
541
0.430
Why?
Trastuzumab
7
2016
89
0.430
Why?
Caspases
4
2009
243
0.430
Why?
Lymphatic Metastasis
16
2021
275
0.420
Why?
Genistein
2
2010
11
0.410
Why?
Female
64
2022
59324
0.400
Why?
Antineoplastic Agents, Hormonal
5
2020
138
0.390
Why?
Receptors, Steroid
1
2012
46
0.380
Why?
Signal Transduction
15
2018
4501
0.380
Why?
Antimetabolites, Antineoplastic
1
2012
80
0.380
Why?
Drug Resistance, Neoplasm
9
2016
636
0.380
Why?
STAT3 Transcription Factor
1
2012
172
0.350
Why?
Neoplasm Invasiveness
7
2016
438
0.350
Why?
Genes, p53
5
2000
61
0.340
Why?
Humans
81
2023
114045
0.330
Why?
Neoplasm Proteins
5
2016
385
0.320
Why?
Glucose
1
2013
899
0.310
Why?
Glycoproteins
2
2005
304
0.300
Why?
Intracellular Signaling Peptides and Proteins
2
2010
388
0.300
Why?
Mice
17
2022
14843
0.300
Why?
Mammary Tumor Virus, Mouse
2
2004
42
0.280
Why?
Mice, Transgenic
8
2018
1947
0.280
Why?
MicroRNAs
4
2021
600
0.280
Why?
MCF-7 Cells
4
2020
105
0.270
Why?
Carcinoma
4
1995
198
0.270
Why?
Protein Kinase Inhibitors
3
2016
784
0.260
Why?
Doxorubicin
9
2011
286
0.250
Why?
Bromodeoxyuridine
2
1999
72
0.250
Why?
Polymerase Chain Reaction
6
2021
990
0.250
Why?
Animals
22
2022
31565
0.240
Why?
Xenograft Model Antitumor Assays
3
2020
695
0.240
Why?
Antibodies, Monoclonal
6
2013
1257
0.240
Why?
Tyrosine
2
2007
210
0.230
Why?
Radiation Tolerance
1
2005
92
0.230
Why?
Quinazolines
2
2016
240
0.220
Why?
Phosphorylation
5
2011
1558
0.220
Why?
Cell Survival
5
2018
1014
0.220
Why?
Cocarcinogenesis
1
2003
14
0.220
Why?
Isoflavones
1
2003
16
0.220
Why?
Paclitaxel
4
2015
190
0.210
Why?
Seminoma
1
2023
17
0.210
Why?
Multivariate Analysis
7
2005
1422
0.210
Why?
Receptors, Progesterone
5
2012
319
0.210
Why?
Chromosomes
1
2003
85
0.210
Why?
Chromosomes, Human, Pair 8
1
2002
33
0.200
Why?
Cyclins
2
2000
78
0.200
Why?
Chromosome Aberrations
1
2002
134
0.190
Why?
Enzyme Activation
3
2009
771
0.190
Why?
Obesity
4
2022
2505
0.190
Why?
Ki-67 Antigen
3
2014
102
0.190
Why?
Rats
7
2022
4913
0.190
Why?
Diet
3
2018
1080
0.190
Why?
Cyclophosphamide
7
2011
214
0.190
Why?
Orchiectomy
1
2021
57
0.190
Why?
Breast
4
2018
138
0.190
Why?
Retroperitoneal Neoplasms
1
2021
22
0.180
Why?
Survival Analysis
7
2005
1206
0.180
Why?
Neoplasm Staging
8
2021
1162
0.180
Why?
Neoplastic Stem Cells
2
2014
327
0.180
Why?
Middle Aged
26
2021
26605
0.180
Why?
Teratoma
1
2021
92
0.170
Why?
TOR Serine-Threonine Kinases
3
2012
359
0.170
Why?
Phosphatidylinositol 3-Kinases
3
2011
328
0.170
Why?
Ovarian Neoplasms
4
1995
386
0.170
Why?
Mice, SCID
1
2020
312
0.170
Why?
Proto-Oncogene Proteins
5
2008
607
0.160
Why?
Carcinoma, Papillary
1
1999
74
0.160
Why?
Mitotic Index
1
1999
26
0.160
Why?
Mice, Inbred NOD
1
2020
552
0.160
Why?
Chemotherapy, Adjuvant
5
2015
332
0.160
Why?
Antigens, Neoplasm
2
2009
222
0.160
Why?
Receptors, Androgen
2
2017
131
0.160
Why?
Autism Spectrum Disorder
1
2023
322
0.150
Why?
Drug Synergism
3
2018
315
0.150
Why?
Aromatase
1
2018
30
0.150
Why?
Kaplan-Meier Estimate
1
2020
813
0.150
Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2018
48
0.150
Why?
HSP90 Heat-Shock Proteins
1
2018
43
0.150
Why?
Phenylthiohydantoin
2
2017
40
0.150
Why?
Ovariectomy
4
2022
116
0.140
Why?
Down-Regulation
3
2010
594
0.140
Why?
Tumor Burden
4
2022
258
0.140
Why?
Fluorouracil
5
2009
152
0.140
Why?
In Situ Hybridization, Fluorescence
4
2008
308
0.140
Why?
Poly(ADP-ribose) Polymerases
2
2009
87
0.140
Why?
Cell Division
4
2005
754
0.140
Why?
Postmenopause
5
2022
301
0.140
Why?
Estrogen Receptor alpha
2
2018
121
0.140
Why?
Triazoles
1
2018
125
0.140
Why?
Organic Cation Transport Proteins
1
2017
26
0.140
Why?
Caspase 3
3
2006
234
0.140
Why?
Receptor Protein-Tyrosine Kinases
1
2018
224
0.130
Why?
Smad Proteins
1
2016
39
0.130
Why?
Ovary
1
2017
190
0.130
Why?
Gene Knock-In Techniques
1
2016
46
0.130
Why?
Calcitriol
1
2016
53
0.130
Why?
Estrogens
1
2018
312
0.130
Why?
Proteins
2
1992
906
0.120
Why?
Mental Disorders
1
2023
889
0.120
Why?
Drug Screening Assays, Antitumor
2
2016
181
0.120
Why?
Protein Tyrosine Phosphatases
1
2016
147
0.120
Why?
Gene Amplification
2
2009
95
0.120
Why?
Fatty Acid Synthase, Type I
1
2014
5
0.120
Why?
Disease Progression
6
2018
2371
0.120
Why?
Mice, Knockout
1
2020
2562
0.120
Why?
Immunoradiometric Assay
1
1994
2
0.120
Why?
Cathepsin D
1
1994
14
0.110
Why?
Antibodies, Monoclonal, Humanized
4
2013
660
0.110
Why?
Postpartum Period
2
2014
275
0.110
Why?
Immunoprecipitation
2
2011
151
0.110
Why?
Tumor Cells, Cultured
5
2009
845
0.110
Why?
Androgen Receptor Antagonists
1
2014
30
0.110
Why?
Adenocarcinoma
3
2012
787
0.110
Why?
Insulin-Like Growth Factor I
1
2016
286
0.110
Why?
Androgen Antagonists
1
2014
69
0.110
Why?
Transforming Growth Factor beta
1
2016
445
0.110
Why?
Receptor, ErbB-4
2
2010
18
0.110
Why?
Cyclin-Dependent Kinase Inhibitor p27
2
2010
69
0.110
Why?
Vitamin D
1
2016
340
0.100
Why?
Disease Models, Animal
4
2017
3498
0.100
Why?
Blotting, Western
3
2011
1143
0.100
Why?
Overnutrition
1
2012
30
0.100
Why?
RNA, Messenger
4
2016
2550
0.100
Why?
Nucleic Acid Hybridization
2
2003
187
0.100
Why?
Gene Expression Profiling
2
2016
1518
0.100
Why?
Aminosalicylic Acids
1
2012
5
0.100
Why?
DNA, Neoplasm
6
2005
155
0.100
Why?
Benzenesulfonates
1
2012
19
0.100
Why?
Proto-Oncogene Proteins c-bcl-2
2
2007
211
0.100
Why?
Carcinoma, Intraductal, Noninfiltrating
1
1992
49
0.100
Why?
Chromones
1
2011
35
0.100
Why?
Cohort Studies
2
2020
4883
0.100
Why?
Proportional Hazards Models
4
2005
1078
0.090
Why?
Genital Diseases, Female
1
1991
25
0.090
Why?
Dasatinib
1
2011
45
0.090
Why?
Fluoxymesterone
1
1991
2
0.090
Why?
Mitosis
3
2001
164
0.090
Why?
Apoptosis Regulatory Proteins
1
2012
170
0.090
Why?
Thiazoles
1
2011
110
0.090
Why?
S Phase
2
2010
69
0.090
Why?
Weight Gain
3
2022
453
0.090
Why?
Morpholines
1
2011
102
0.090
Why?
Reagent Kits, Diagnostic
1
1991
42
0.090
Why?
Neoplasm Metastasis
5
2005
521
0.090
Why?
Genital Neoplasms, Female
1
1991
70
0.090
Why?
Aged
12
2015
18969
0.090
Why?
Chromosomes, Human, Pair 17
3
2002
56
0.090
Why?
Adult
15
2021
30375
0.080
Why?
Flow Cytometry
3
2007
1075
0.080
Why?
Proto-Oncogenes
1
1989
26
0.080
Why?
Dose-Response Relationship, Drug
2
2008
1836
0.080
Why?
Antibiotics, Antineoplastic
2
2009
110
0.080
Why?
Radioisotopes
1
1989
28
0.080
Why?
Anthracyclines
1
2009
42
0.080
Why?
DNA Topoisomerases, Type II
1
2009
44
0.080
Why?
Treatment Outcome
5
2007
9049
0.080
Why?
DNA-Binding Proteins
2
2009
1311
0.080
Why?
Pyrimidines
1
2011
374
0.080
Why?
Epithelial Cells
1
2014
946
0.080
Why?
Mutation
3
1995
3338
0.080
Why?
MAP Kinase Signaling System
1
2010
271
0.070
Why?
Gene Deletion
2
2002
356
0.070
Why?
AMP-Activated Protein Kinases
1
2009
170
0.070
Why?
RNA, Small Interfering
2
2007
534
0.070
Why?
Energy Metabolism
1
2012
727
0.070
Why?
Mice, Nude
1
2009
628
0.070
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2010
924
0.070
Why?
Gene Dosage
1
2008
129
0.070
Why?
Time Factors
4
2015
6077
0.070
Why?
Transcription Factors
2
2008
1526
0.070
Why?
Protein Structure, Tertiary
1
2009
796
0.070
Why?
Immunoenzyme Techniques
3
1999
192
0.070
Why?
Proto-Oncogene Proteins c-akt
3
2016
397
0.070
Why?
Mitochondria
3
2008
744
0.070
Why?
Enzyme Precursors
1
2006
15
0.070
Why?
Epigenesis, Genetic
1
2010
518
0.070
Why?
Receptor, Notch1
1
2006
59
0.060
Why?
Multigene Family
2
2003
190
0.060
Why?
Age Factors
3
2003
2885
0.060
Why?
Lamin Type B
1
2005
5
0.060
Why?
Tumor Microenvironment
2
2018
428
0.060
Why?
Herpes Simplex
1
2006
87
0.060
Why?
Herpesvirus 1, Human
1
2006
76
0.060
Why?
Follow-Up Studies
4
2007
4392
0.060
Why?
Aged, 80 and over
4
2000
6306
0.060
Why?
Nitriles
2
2017
149
0.060
Why?
Cell Nucleolus
1
2005
17
0.060
Why?
Benzamides
2
2017
168
0.060
Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2007
107
0.060
Why?
Feedback
1
2005
144
0.060
Why?
RNA Interference
3
2015
431
0.060
Why?
Predictive Value of Tests
4
2011
1791
0.060
Why?
Adipose Tissue
2
2018
545
0.060
Why?
Protein Kinases
1
2006
304
0.060
Why?
Rats, Wistar
2
2017
368
0.060
Why?
Tacrolimus Binding Protein 1A
1
2003
7
0.060
Why?
Tacrolimus Binding Proteins
1
2003
16
0.060
Why?
Mice, Inbred Strains
1
2004
398
0.050
Why?
Genes, Tumor Suppressor
1
2003
77
0.050
Why?
Estrogens, Non-Steroidal
1
2003
5
0.050
Why?
Phytoestrogens
1
2003
13
0.050
Why?
Plant Preparations
1
2003
23
0.050
Why?
Estrogen Antagonists
1
2003
39
0.050
Why?
Lymph Node Excision
2
2021
140
0.050
Why?
Cell Line
2
2003
2629
0.050
Why?
Actins
1
2005
376
0.050
Why?
Anticarcinogenic Agents
1
2003
66
0.050
Why?
Chromosome Banding
1
2002
21
0.050
Why?
Mammary Glands, Animal
1
2003
117
0.050
Why?
Chromosomes, Human, Pair 16
1
2002
30
0.050
Why?
Rodentia
1
2022
43
0.050
Why?
Transfection
3
2015
863
0.050
Why?
3' Untranslated Regions
2
2014
129
0.050
Why?
Nuclear Proteins
2
2000
591
0.050
Why?
Trefoil Factor-1
2
1992
2
0.050
Why?
alpha-Fetoproteins
1
2021
31
0.050
Why?
Fallopian Tubes
2
1991
29
0.050
Why?
In Situ Nick-End Labeling
1
2001
119
0.050
Why?
Chorionic Gonadotropin
1
2021
78
0.050
Why?
Sweden
1
2021
65
0.050
Why?
RNA, Catalytic
1
2002
181
0.050
Why?
Plasmids
1
2002
343
0.050
Why?
RNA Stability
1
2021
90
0.040
Why?
Neoplasm, Residual
1
2021
104
0.040
Why?
Antigens, Nuclear
1
2000
19
0.040
Why?
Breast Diseases
1
2000
20
0.040
Why?
Reproducibility of Results
2
2021
2764
0.040
Why?
Enhancer Elements, Genetic
1
2000
151
0.040
Why?
Integrin beta3
2
2013
9
0.040
Why?
Telomerase
1
2001
204
0.040
Why?
Tumor Suppressor Proteins
2
1992
283
0.040
Why?
Case-Control Studies
2
2023
3003
0.040
Why?
N-Glycosyl Hydrolases
1
1998
5
0.040
Why?
DNA Glycosylases
1
1998
6
0.040
Why?
Methylnitrosourea
1
2018
6
0.040
Why?
Loss of Function Mutation
1
2018
36
0.040
Why?
Antibodies
1
2000
365
0.040
Why?
Retrospective Studies
4
2005
12521
0.040
Why?
G2 Phase Cell Cycle Checkpoints
1
2018
41
0.040
Why?
Trans-Activators
1
2000
366
0.040
Why?
NF-kappa B
1
2002
636
0.040
Why?
Half-Life
1
2018
141
0.040
Why?
Codon
3
1993
85
0.040
Why?
Stromal Cells
1
2018
96
0.040
Why?
Hyaluronan Receptors
1
1998
90
0.040
Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1998
170
0.040
Why?
Gene Expression
3
2013
1417
0.040
Why?
Organic Cation Transporter 2
1
2017
8
0.040
Why?
Extracellular Matrix Proteins
1
1998
126
0.030
Why?
Antigens, CD
2
2014
440
0.030
Why?
DNA Repair
1
1998
184
0.030
Why?
Steroids
1
2017
143
0.030
Why?
Proto-Oncogene Proteins pp60(c-src)
1
2016
11
0.030
Why?
Chromatography, Liquid
1
2017
345
0.030
Why?
Survival Rate
3
1998
1638
0.030
Why?
Oncogenes
1
2016
104
0.030
Why?
RNA
1
2001
806
0.030
Why?
Phosphatidylinositol 3-Kinase
1
2015
26
0.030
Why?
Oncogene Proteins
1
1995
53
0.030
Why?
Cell Nucleus
3
2006
552
0.030
Why?
Homeodomain Proteins
1
2018
465
0.030
Why?
Analysis of Variance
2
2014
1218
0.030
Why?
Mammary Glands, Human
1
2014
60
0.030
Why?
Mass Spectrometry
1
2017
622
0.030
Why?
Tosyl Compounds
1
2014
14
0.030
Why?
Neoplasms
2
2012
2086
0.030
Why?
Brain Neoplasms
2
1993
966
0.030
Why?
Integrin alpha6
1
2013
8
0.030
Why?
Testosterone
1
2017
341
0.030
Why?
Leukocyte Common Antigens
1
2014
75
0.030
Why?
Antigens, Differentiation, Myelomonocytic
1
2014
53
0.030
Why?
Gene Expression Regulation, Enzymologic
1
2015
270
0.030
Why?
Sirolimus
2
2006
181
0.030
Why?
Parity
1
2014
97
0.030
Why?
Immunoassay
1
1994
95
0.030
Why?
Premenopause
1
2014
105
0.030
Why?
Anilides
1
2014
67
0.030
Why?
Interleukin-6
1
2017
673
0.030
Why?
Neovascularization, Pathologic
1
1995
280
0.030
Why?
Transplantation, Heterologous
1
2014
180
0.030
Why?
Neoplasm Transplantation
1
2014
227
0.030
Why?
bcl-2-Associated X Protein
2
2007
45
0.030
Why?
Young Adult
2
2021
10444
0.030
Why?
Organ Specificity
1
2013
266
0.030
Why?
Lactation
1
2014
149
0.030
Why?
Inhibitor of Apoptosis Proteins
1
2013
42
0.030
Why?
Immune System
1
2014
171
0.030
Why?
Molecular Targeted Therapy
1
2015
347
0.030
Why?
Lipogenesis
1
2012
56
0.030
Why?
Point Mutation
1
1993
216
0.030
Why?
Astrocytoma
1
1993
106
0.020
Why?
Tumor Necrosis Factor-alpha
2
2007
1128
0.020
Why?
Broad Ligament
1
1991
1
0.020
Why?
Gene Knockdown Techniques
1
2013
301
0.020
Why?
Peritoneum
1
1991
36
0.020
Why?
Glycolysis
1
2012
224
0.020
Why?
Pilot Projects
1
2015
1360
0.020
Why?
Pregnancy
2
2014
5499
0.020
Why?
Mucins
1
1991
61
0.020
Why?
Pregnancy Complications, Neoplastic
1
1991
51
0.020
Why?
Blotting, Northern
1
2010
193
0.020
Why?
Evaluation Studies as Topic
1
1991
167
0.020
Why?
Hormones
1
1991
132
0.020
Why?
Soft Tissue Neoplasms
1
1991
89
0.020
Why?
Cells, Cultured
2
2013
3861
0.020
Why?
Glioblastoma
1
1993
250
0.020
Why?
In Situ Hybridization
1
2010
292
0.020
Why?
Prospective Studies
1
2021
6195
0.020
Why?
Risk Factors
1
2003
8614
0.020
Why?
Precipitin Tests
1
1989
88
0.020
Why?
Radionuclide Imaging
1
1989
115
0.020
Why?
Odds Ratio
1
1992
951
0.020
Why?
Protein Multimerization
1
2010
157
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2010
742
0.020
Why?
Lymph Nodes
1
1991
415
0.020
Why?
Drug Interactions
1
2009
337
0.020
Why?
Membrane Potential, Mitochondrial
1
2007
55
0.020
Why?
Male
3
2023
55396
0.020
Why?
Cytochromes c
1
2007
60
0.020
Why?
Apoptotic Protease-Activating Factor 1
1
2007
2
0.020
Why?
Biomarkers
1
2017
3397
0.020
Why?
Aging
2
2002
1611
0.020
Why?
Caspase 10
1
2006
5
0.020
Why?
Amino Acid Sequence
3
1998
1981
0.020
Why?
Caspase 2
1
2006
14
0.020
Why?
Caspase 8
1
2006
43
0.020
Why?
Caspase 9
1
2006
48
0.020
Why?
Cysteine Endopeptidases
1
2006
60
0.020
Why?
Leukemia-Lymphoma, Adult T-Cell
1
2006
12
0.020
Why?
Caspase 7
1
2006
20
0.020
Why?
Eukaryotic Initiation Factor-4E
1
2006
27
0.020
Why?
Isoenzymes
1
2007
283
0.020
Why?
Antineoplastic Agents, Phytogenic
1
2007
181
0.020
Why?
Vero Cells
1
2006
63
0.020
Why?
Cytosol
1
2006
201
0.020
Why?
Promoter Regions, Genetic
1
2010
1131
0.020
Why?
Virus Assembly
1
2006
66
0.020
Why?
Base Sequence
2
2003
2114
0.020
Why?
Adolescent
2
2021
17800
0.020
Why?
Protein Binding
1
2010
1888
0.010
Why?
Protein Processing, Post-Translational
1
2006
399
0.010
Why?
Taxoids
1
2004
93
0.010
Why?
Mice, Inbred C57BL
2
2003
4680
0.010
Why?
DNA, Complementary
1
2003
255
0.010
Why?
Melanoma, Experimental
1
2003
89
0.010
Why?
Cell Adhesion
1
2003
426
0.010
Why?
Platelet Membrane Glycoproteins
1
2002
33
0.010
Why?
Exons
2
1993
301
0.010
Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2002
57
0.010
Why?
Gene Targeting
1
2002
75
0.010
Why?
Templates, Genetic
1
2001
59
0.010
Why?
Substrate Specificity
1
2002
350
0.010
Why?
Molecular Sequence Data
2
1998
2783
0.010
Why?
DNA, Superhelical
1
2000
11
0.010
Why?
DNA Footprinting
1
2000
28
0.010
Why?
Mice, Inbred BALB C
1
2003
1144
0.010
Why?
Proto-Oncogene Proteins c-ets
1
2000
51
0.010
Why?
Genes, erbB
1
2000
2
0.010
Why?
Ploidies
1
2000
17
0.010
Why?
Repetitive Sequences, Nucleic Acid
1
2000
104
0.010
Why?
Macromolecular Substances
1
2000
200
0.010
Why?
Pathology, Clinical
1
2000
32
0.010
Why?
Gene Silencing
1
2000
171
0.010
Why?
Multicenter Studies as Topic
1
2000
249
0.010
Why?
Genetic Therapy
1
2000
256
0.010
Why?
Forecasting
1
2000
331
0.010
Why?
Receptors, Cell Surface
1
2000
350
0.010
Why?
Binding Sites
1
2000
1166
0.010
Why?
Nucleic Acid Conformation
1
2000
670
0.010
Why?
ras Proteins
1
1998
138
0.010
Why?
Chromosomes, Human, Pair 13
1
1996
16
0.010
Why?
Chromosomes, Human, Pair 3
1
1996
49
0.010
Why?
Chromosomes, Human, Pair 11
1
1996
57
0.010
Why?
Societies, Medical
1
2000
655
0.010
Why?
Adenine
1
1998
218
0.010
Why?
Immunoblotting
1
1997
282
0.010
Why?
United States
2
2004
12137
0.010
Why?
Hyaluronic Acid
1
1998
189
0.010
Why?
Heterozygote
1
1996
250
0.010
Why?
Melanoma
1
2002
620
0.010
Why?
Protein Isoforms
1
1997
337
0.010
Why?
Randomized Controlled Trials as Topic
1
2000
1204
0.010
Why?
Polymorphism, Single-Stranded Conformational
1
1995
25
0.010
Why?
Factor VIII
1
1995
52
0.010
Why?
Cyclin D1
1
1995
61
0.010
Why?
Transcription, Genetic
1
2000
1310
0.010
Why?
Single-Blind Method
1
1995
259
0.010
Why?
Observer Variation
1
1995
298
0.010
Why?
Alleles
1
1996
789
0.010
Why?
Biopsy
1
1995
1024
0.010
Why?
Proliferating Cell Nuclear Antigen
1
1991
49
0.010
Why?
Risk Assessment
1
2000
2958
0.010
Why?
Peripheral Nerves
1
1991
64
0.010
Why?
DNA
1
1996
1350
0.010
Why?
Protein Conformation
1
1993
803
0.010
Why?
Polymorphism, Genetic
1
1993
610
0.010
Why?
Lung Neoplasms
1
2002
2159
0.010
Why?
Cerebral Cortex
1
1991
380
0.000
Why?
Glioma
1
1991
285
0.000
Why?
Child
1
1993
18401
0.000
Why?
Thor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)